The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.
 
Kei Muro
No Relationships to Disclose
 
Yung-Jue Bang
No Relationships to Disclose
 
Veena Shankaran
No Relationships to Disclose
 
Ravit Geva
No Relationships to Disclose
 
Daniel Virgil Thomas Catenacci
No Relationships to Disclose
 
Shilpa Gupta
No Relationships to Disclose
 
Joseph Paul Eder
No Relationships to Disclose
 
Raanan Berger
No Relationships to Disclose
 
Edward J. Gonzalez
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Archana Ray
Employment - Merck
 
Marisa Dolled-Filhart
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kenneth Emancipator
Employment - Merck
Stock and Other Ownership Interests - Bayer; Celgene (I); Johnson & Johnson (I); Merck
 
Kumudu Pathiraja
Employment - Merck
 
Jared K. Lunceford
Employment - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Minori Koshiji
Employment - Merck
 
Hyun Cheol Chung
No Relationships to Disclose